Be a Smart Investor
Thursday, December 6, 2018
No Respite For MiMedx, CNAT Fails NASH Trial, NDRA On Watch
The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.
from RTT - Biotech https://ift.tt/2zPdFCN
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment